We found that knockdown of NAT10 significantly reduced the expression of LINC02802 (Figure 9B-9C), and treatment of lung cancer cells with the NAT10 inhibitor remodelin also downregulated LINC02802 expression (Figure 9D). The gene discussed is NAT10; the disease is lung cancer.